Discussioni template:Terapie alternative: differenze tra le versioni

Versione delle 01:58, 5 dic 2010

Versione delle 01:59, 5 dic 2010

Riga 240:

products, however, requires consideration of issues of safety, efficacy and

quality. This is the basis of consumer protection and is no different, in principle,

from what underpins modern medical practice. |World Health Organization, [http://apps.who.int/medicinedocs/documents/s17552en/s17552en.pdf Benchmarks for training in traditional /complementary and alternative medicine: benchmarks for training in Ayurveda.], p.8}}

medicine: benchmarks for training in Ayurveda.], p.8}}